Dental Management of Patients with Stroke or Alzheimer's Disease

Dental Clinics of North America

Volumn 50, Issue 4, 2006, Pages 625-633

  Sacco, Debra ^a   Frost, David E ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; CEREBROVASCULAR ACCIDENT; DENTAL CARE; HUMAN; PATHOPHYSIOLOGY; REVIEW; STROKE;

ALZHEIMER DISEASE; CEREBROVASCULAR ACCIDENT; DENTAL CARE FOR CHRONICALLY ILL; HUMANS; STROKE;

EID: 33748774162     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cden.2006.08.001     Document Type: Review

References (18)

1. Chen Z.M., Sandercock P., Pan H.C., et al. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40,000 randomized patients from the Chinese acute stroke trial and the international stroke trial. Stroke 31 (2000) 1240-1249
2. Sherman D.G. Heparin and heparinoids in stroke. Neurology 51 Suppl 3 (1998) S56-S58
3. Siener H.C., Darius H., Bertrand-Hardy J.M., et al. European Stroke Prevention Study 2 (ESPS2). Cardiac safety in the ESPS2. Int J Clin Pract 55 (2001) 162-163
4. Bhatt D.L., Hirsch A.T., Ringleb P.A., et al. Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. Am Heart J 140 (2000) 67-73
5. Diener H.C., Bogousslavsky J., Brass L.M., et al. Aspirin and clopidogrel compared with cloidogreal alone after recent ischaemic stroke or transient ischaemic attack in the high-risk patients (MATCH). Lancet 364 (2004) 331-337
6. Smith W.S., Sung G., Starkman S., et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36 (2005) 1432-1438
7. Alexandrov A.V., Molina C.A., Grotta J.C., et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 351 (2004) 2170-2178
8. Alexandrov A.V. Ultrasound identification and lysis of clots. Stroke 35 Suppl 1 (2004) 2722-2725
9. Molina C.A., RIbo M., Rubiera M., et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 37 2 (2006) 425-429
10. Mohr J.P., Thompson J.L., Lazar R.M., et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 345 (2001) 1444-1451
11. Wu T., Trevisan M., Genco R.J., et al. Periodontal disease and risk of cerebrovascular disease: the first national health and nutrition examination survey and its follow-up study. Arch Intern Med 160 (2000) 2749-2755
12. Engebretson S.P., Lamster I.B., Elkind M.S., et al. Radiographic measures of chronic periodontitis and carotid artery plaque. Stroke 36 (2005) 561-566
13. Holtzer R., Scarmeas N., Wegesin D.J., et al. Depressive symptoms in Alzheimer's disease: natural course and temporal relation to function and cognitive status. J Am Geriatr Soc 53 (2005) 2083-2089
14. Reiss A.B. Cholesterol and apolipoprotein E in Alzheimer's disease. Am J Alzheimers Dis Other Demen 20 2 (2005) 91-96
15. Masse I., Bordet R., Deplanque D., et al. Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 76 (2005) 1611-1613
16. Reisberg B., Doody R., Stoffler A., et al. A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease. Arch Neurol 63 (2006) 49-54
17. Clader J.W., and Wang Y. Muscarinic receptor agonists and antagonists in the treatment of Alzheimer's disease. Curr Pharm Dis 11 (2005) 3353-3361
18. Petersen R.C., Thomas R.G., Grundman M., et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 353 (2005) 2379-2388